Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)
About
The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.
The Tuberculosis Research Advancement Centers (TRACs) program, funded through a P30 mechanism, is designed to support institutions and research teams committed to advancing tuberculosis (TB) science and developing the next generation of TB researchers. This grant program provides comprehensive support for basic and clinical TB research through expertise, resources, and multidisciplinary collaboration. TRACs is ideal for research institutions, universities, and medical centers with established TB research programs seeking to catalyze innovative science and build research capacity. The program emphasizes developing early-career researchers and fostering collaborative, multidisciplinary approaches to TB research challenges. Funding ranges from up to $600,000 and supports the infrastructure, shared resources, and expertise needed to strengthen TB research programs. This opportunity is particularly valuable for institutions looking to establish or expand their TB research capabilities, create training pipelines for future TB researchers, and tackle critical gaps in tuberculosis science. Applicants should note that clinical trials are not allowed under this funding mechanism. For complete eligibility requirements and application procedures, prospective applicants should consult the official Notice of Funding Opportunity (NOFO) and contact the National Institutes of Health (NIH) directly.
Funding Facts
● Applications openDeadline
July 10, 2026
Award Amount
Up to $600K
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Grant Amount
Up to $600K
Deadline
2026-07-10
Grant Type
federal
Application Cycle
Annual
Best For
Research institutions, universities, and medical centers with tuberculosis research programs seeking to advance TB science and develop the next generation of researchers
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations: Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement are not allowed.
Frequently Asked Questions
Who is eligible for Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)?
Eligible applicants include domestic (U.S.) institutions, organizations, and research centers with the capacity to conduct tuberculosis research. Non-domestic (non-U.S.) entities, foreign organizations, and non-domestic components of U.S. organizations are not eligible to apply. Foreign components as defined in the NIH Grants Policy Statement are also not permitted. For detailed eligibility criteria, refer to Section III of the official Notice of Funding Opportunity (NOFO) or contact the NIH directly.
How much funding does Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) provide?
The TRACs program provides funding up to $600,000. The exact amount awarded may vary based on the scope of the proposed research program, institutional capacity, and specific project needs. Prospective applicants should review the current NOFO for specific budget guidelines and funding limitations for their funding cycle.
How do I apply for Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)?
Applications are submitted through the NIH application portal (Grants.gov or eRA Commons). The next deadline is July 10, 2026. Prospective applicants should thoroughly review the official Notice of Funding Opportunity (NOFO) for specific submission requirements, required components, and formatting guidelines. It is strongly recommended to contact the NIH program officer for your research area prior to submission to ensure alignment with program goals.
What can Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) funding be used for?
TRACs funding supports basic and clinical tuberculosis research infrastructure, shared resources, and expertise to advance TB science. Funding can be used to develop research capacity, provide training and mentorship for early-career TB researchers, and facilitate multidisciplinary collaboration. Note that this grant mechanism does not support clinical trials. Consult the official NOFO for a comprehensive list of allowable and unallowable expenses.
Last updated: July 5, 2026